FH Joanneum Gesellschaft mbH
8
2
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers
Role: lead
LETHE-AT: a Personalized Multidomain Lifestyle Intervention for Individuals at Increased Risk of Memory Impairment.
Role: collaborator
IOBBAT - Impact of Basic Body Awareness Therapy on Body Awareness
Role: collaborator
Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers
Role: collaborator
Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults
Role: collaborator
Endothelial Dysfunction in Post-infection Fatigue Syndromes
Role: lead
Validation Study SCOBES-AR
Role: lead
Test and Usability of Mixed-reality Screening Tool for Early Detection of Cognitive Declines
Role: lead
All 8 trials loaded